Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Block Listing Application

8 Mar 2016 09:00

RNS Number : 2351R
Premier Veterinary Group PLC
08 March 2016
 

 

 

 

BLOCK LISTING APPLICATION

 

 

London, 8 March 2016: Premier Veterinary Group plc (LSE: PVG) (the "Company") announces that it has made a block listing application to the London Stock Exchange for the admission of up to 1,674,212 ordinary shares of 10 pence each to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities.

 

The block listing application relates to the following:

 

Warrants

 

As part of the arrangements relating to the reverse acquisition by the Company of Premier Veterinary Group Limited (now PVG 2007 Limited) completed in February 2015, warrants were granted over 279,034 ordinary shares of 10 pence each, vesting and becoming exercisable in two equal tranches on 27 February 2016 and 27 February 2017 respectively.

The block listing application is for the total number of shares that could be issued pursuant to the exercise of all of those warrants, representing approximately 2% of the current issued share capital. The application for the admission of these shares has been made in advance for ease of administration.

Further information relating to the warrants can be found in the Company's Annual Report and Accounts 2015 available on its website: www.premiervetgroup.co.uk.

Share options

 

The block listing application also includes a further 1,395,178 shares, being the total number of shares that could be issued pursuant to the exercise of all options currently outstanding under the 2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan (the "EMI Plan"). If all the options were exercised, the shares that would be issued would represent approximately 10% of the current issued share capital.

The application for the admission of these shares has been made in advance for ease of administration as all the outstanding options under the EMI Plan vested and became exercisable on 27 February 2016.

 

 

Shares issued pursuant to the exercise of the warrants and the options under the EMI Plan will rank pari passu with the existing ordinary shares of 10 pence each in the share capital of the Company.

 

It is expected that the block admission will become effective on 9 March 2016.

 

 

Enquiries:

 

Premier Veterinary Group plc

Sue Steven, Company Secretary +44 (0)117 370 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISSSFSUWFMSELD
Date   Source Headline
22nd Apr 20093:34 pmRNSAGM Results
7th Apr 200911:09 amRNSAnnual Information Update
7th Apr 20097:00 amRNSResearch Update
17th Mar 20095:03 pmRNSHolding(s) in Company
13th Mar 20094:25 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSFinal Results
2nd Mar 200911:21 amRNSVoting Rights and Capital
26th Feb 20097:00 amRNSPatent Filing
17th Feb 20092:14 pmRNSHolding(s) in Company
16th Feb 20095:39 pmRNSHolding(s) in Company
16th Feb 20097:00 amRNSResearch Update
5th Feb 200910:50 amRNSDealing by Employee Benefit Trust
2nd Feb 20097:00 amRNSDirector/PDMR Shareholding
21st Jan 20094:40 pmRNSSecond Price Monitoring Extn
21st Jan 20094:37 pmRNSPrice Monitoring Extension
21st Jan 200912:12 pmRNSNotice of Results
14th Jan 20097:00 amRNSRe Agreement
9th Jan 200910:23 amRNSHolding(s) in Company
8th Jan 20097:00 amRNSTrinam Phase III trial to commence
6th Jan 20097:00 amRNSResearch Update
31st Dec 20089:00 amRNSTotal Voting Rights
16th Dec 20083:46 pmRNSNotification of Major Interests in Shares
9th Dec 20084:40 pmRNSSecond Price Monitoring Extn
9th Dec 20084:35 pmRNSPrice Monitoring Extension
9th Dec 20087:00 amRNSRegulatory Approval
5th Dec 20082:28 pmRNSBlocklisting Six Monthly Return
1st Dec 20087:00 amRNSRegulatory Application
24th Nov 200811:58 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSInterim Management Statement
20th Oct 20087:00 amRNSProduct Launch
2nd Oct 20087:00 amRNSArk secures reimbursement for Neuropad
30th Sep 20085:06 pmRNSVoting Rights and Capital
17th Sep 20081:08 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
27th Aug 20087:00 amRNSResearch Update
26th Aug 20084:08 pmRNSHolding(s) in Company
1st Aug 200810:47 amRNSVoting Rights and Captial
31st Jul 20081:12 pmRNSHolding(s) in Company
30th Jul 20087:00 amRNSResearch Update
16th Jul 20087:00 amRNSResearch Update
8th Jul 200811:00 amRNSArk opens new manufacturing f
24th Jun 200811:28 amRNSHolding(s) in Company
18th Jun 20087:00 amRNSResearch Update
6th Jun 200812:10 pmRNSBlocklisting Application
3rd Jun 200810:58 amRNSBlocklisting Interim Review
3rd Jun 200810:51 amRNSBlocklisting Interim Review
2nd Jun 20087:00 amRNSRegulatory Approval
30th May 20084:52 pmRNSVoting Rights and Capital
30th May 20087:00 amRNSResearch Update
22nd May 20081:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.